期刊文献+

COX-2基因–765G>C位点多态性与结直肠癌易感性的meta分析

Correlation between –765G>C polymorphism of cyclooxygenase-2 gene and susceptibility to colorectal cancer: a meta-analysis
原文传递
导出
摘要 目的采用meta分析的方法定量评价环氧化酶-2(COX-2)基因–765G>C位点多态性与结直肠癌易感性的关系。方法计算机检索Pub Med、Embase、The Cochrane Library、CNKI、CBM、VIP和万方数据库,搜集有关COX-2基因–765G>C位点多态性与结直肠癌发病风险相关性的病例对照研究,检索时限均从建库至2016年5月。由两位评价员独立筛选文献并提取资料,采用Stata 12.0软件进行meta分析。结果共纳入13个病例对照研究,包括4 998例结直肠癌患者和7 750位健康对照者。总体人群的meta分析结果显示:COX-2基因–765G>C位点多态性与结直肠癌易感性无关[GG vs.GC:OR=0.98,95%CI(0.89,1.07),P=0.590;GC vs.CC:OR=0.85,95%CI(0.65,1.11),P=0.236;GG vs.CC:OR=0.86,95%CI(0.66,1.12),P=0.275;GG+GC vs.CC:OR=0.87,95%CI(0.67,1.13),P=0.288);GG vs.GC+CC:OR=0.97,95%CI(0.89,1.05),P=0.425]。亚组分析结果显示,COX-2基因–765G>C位点多态性的GG vs.GC和GG vs.GC+CC模型与亚洲人种结直肠癌的易感性可能有关[GG vs.GC:OR=0.70,95%CI(0.58,0.86),P=0.001;GG vs.GC+CC:OR=0.71,95%CI(0.58,0.87),P=0.001],而其他模型与结直肠癌的易感性无关[GC vs.CC:OR=1.74,95%CI(0.61,5.00),P=0.301;GG vs.CC:OR=1.18,95%CI(0.40,3.45),P=0.762;GG+GC vs.CC:OR=1.50,95%CI(0.53,4.23),P=0.440];COX-2基因–765G>C位点多态性与高加索人种结直肠癌的易感性无关[GG vs.GC:OR=1.05,95%CI(0.95,1.16),P=0.321;GC vs.CC:OR=0.80,95%CI(0.61,1.01),P=0.129;GG vs.CC:OR=0.85,95%CI(0.64,1.11),P=0.228;GG+GC vs.CC:OR=0.83,95%CI(0.64,1.09),P=0.198;GG vs.GC+CC:OR=1.03,95%CI(0.94,1.13),P=0.526]。结论当前证据显示,COX-2基因–765G>C位点多态性可能与亚洲人种结直肠癌易感性有关,而与高加索人种结直肠癌易感性无关。 Objective To evaluate correlation between -765G〉C polymorphism ofcyclooxygenase-2 (COX-2) gene and susceptibility to colorectal cancer. Methods The PubMed, Embase, The Cochrane Library, CNKI, CBM, VIP, and Wanfang databases were searched from inception to May 2016 to collect case-control studies about the -765G〉C polymorphism of COX-2 gene and the susceptibility to colorectal cancer. Two reviewers independently screened the literatures and extracted data of included studies. The meta-analysis was performed using Stata 12.0 software. Results A total of 13 studies involving 4 998 cases and 7 750 controls were included in this meta-analysis. The overall meta-analysis showed that all the genotypes of the -765G〉C polymorphism of COX-2 gene were not associated with the susceptibility to colorectal cancer [ GG vs. GC: OR=0.98, 95% CI (0.89, 1.07), P=0.590; GC vs. CC:OR=0.85, 95% CI (0.65, 1.11), P=0.236; GG vs. CC: OR=0.86, 95% CI (0.66, 1.12), P=0.275; GG+GC vs. CC: OR=0.87, 95% CI (0.67, 1.13), P=0.288; GG vs. GC+CC: 0R=0.97, 95% CI (0.89, 1.05), P=0.425] . The stratification analysis by ethnicity showed that, the GG vs. GC and GG vs. GC+CC modes of COX-2 gene -765G〉C polymorphism might be associated with the susceptibility to colorectal cancer in Asians [ GG vs. GC: OR=0.70, 95%CI (0.58, 0.86), P=0.001; GG vs. GC+CC: OR=0.71, 95% CI (0.58, 0.87), P=0.001 ] , but the other modes were not associated with it [ GC vs. CC: OR=1.74, 95% CI (0.61, 5.00), P=0.301; GG vs. CC: OR=1.18, 95% CI (0.40, 3.45), P=0.762; GG+GC vs. CC: OR=1.50, 95% CI (0.53, 4.23), P=0.440 ] . The genotypes of the -765G〉C polymorphism of COX-2 gene were not associated with the susceptibility to colorectal cancer in Caucasians [ GG vs. GC: OR=1.05, 95% CI (0.95, 1.16), P=0.321; GC vs. CC: OR=0.80, 95% CI (0.61, 1.01), P=0.129; GG vs. CC: OR=0.85, 95% CI (0.64, 1.11), P=0.228; GG+GC vs. CC: OR=0.83, 95% CI (0.64, 1.09), P=0.198; GG vs. GC+CC: OR=1.03, 95% CI (0.94, 1.13), P=0.526 ] . Conclusion Current evidence shows that -765G〉C polymorphism of COX-2 gene might be a genetic risk factor for colorectal cancer in Asians, but not in Caucasians.
出处 《中国普外基础与临床杂志》 CAS 2017年第10期1246-1253,共8页 Chinese Journal of Bases and Clinics In General Surgery
关键词 结直肠癌 环氧化酶-2 META分析 colorectal cancer cyclooxygenase-2 meta-analysis
  • 相关文献

参考文献5

二级参考文献39

  • 1JunYu,Bao-DongTang,WaiK.Leung,Ka-FaiTo,AlfaH.C.Bai,Zhi-RongZeng,Po-KiMa,MinnieY.Y.Go,Pin-JinHu,JosephJ.Y.Sung.Different cell kinetic changes in rat stomach cancer after treatment with celecoxib or indomethacin: Implications on chemoprevention[J].World Journal of Gastroenterology,2005,11(1):41-45. 被引量:38
  • 2Carina Pereira,Hugo Sousa,Paula Ferreira,Maria Fragoso,Luís Moreira-Dias,Carlos Lopes,Rui Medeiros,Mário Dinis-Ribeiro.-765G > C COX-2 polymorphism may be a susceptibility marker for gastric adenocarcinoma in patients with atrophy or intestinal metaplasia[J].World Journal of Gastroenterology,2006,12(34):5473-5478. 被引量:16
  • 3许岸高,姜泊,余志金,钟旭辉,甘爱华,刘集鸿,罗秋云,熊理守.广东省社区人群大肠癌流行病学调查[J].中华医学杂志,2007,87(28):1950-1953. 被引量:24
  • 4Eberhart CE, Coffey RJ, Radhika A, Giardiello FM, Ferrenbach S, DuBois RN. Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas. Gastroenterology 1994; 107: 1183-1188
  • 5Williams CS, Mann M, DuBois RN. The role of cyclooxygenases in inflammation, cancer, and development. Oncogene 1999; 18: 7908-7916
  • 6Bosetti C, Gallus S, La Vecchia C. Aspirin and cancer risk: an updated quantitative review to 2005. Cancer Causes Control 2006; 17: 871-888
  • 7Goodman JE, Bowman ED, Chanock SJ, Alberg AJ, Harris CC. Arachidonate lipoxygenase (ALOX) and cyclooxygenase (COX) polymorphisms and colon cancer risk. Carcinogenesis 2004; 25: 2467-2472
  • 8Siezen CL, Bueno-de-Mesquita HB, Peeters PH, Kram NR, van Doeselaar M, van Kranen HJ. Polymorphisms in the genes involved in the arachidonic acid-pathway, fish consumption and the risk of colorectal cancer. Int J Cancer 2006; 119: 297-303
  • 9Ulrich CM, Whitton J, Yu JH, Sibert J, Sparks R, Potter JD, Bigler J. PTGS2 (COX-2) -765G > C promoter variant reduces risk of colorectal adenoma among nonusers of nonsteroidal anti-inflammatory drugs. Cancer Epidemiol Biomarkers Prev 2005; 14: 616-619
  • 10Cox DG, Pontes C, Guino E, Navarro M, Osorio A, Canzian F, Moreno V. Polymorphisms in prostaglandin synthase 2/cyclooxygenase 2 (PTGS2/COX2) and risk of colorectal cancer. Br J Cancer 2004; 91: 339-343

共引文献58

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部